SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11978170
Source:
http://linkedlifedata.com/resource/pubmed/id/11978170
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0205210
,
umls-concept:C0205314
,
umls-concept:C0281603
,
umls-concept:C0679622
,
umls-concept:C0919418
,
umls-concept:C1152568
,
umls-concept:C1332739
,
umls-concept:C1511576
,
umls-concept:C1527148
pubmed:issue
5
pubmed:dateCreated
2002-4-29
pubmed:abstractText
To review preclinical and clinical information on flavopiridol, an inhibitor of cyclin-dependent kinases (CDKs), tested as an antitumor agent.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9203131
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinases
,
http://linkedlifedata.com/resource/pubmed/chemical/Flavonoids
,
http://linkedlifedata.com/resource/pubmed/chemical/Piperidines
,
http://linkedlifedata.com/resource/pubmed/chemical/flavopiridol
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1060-0280
pubmed:author
pubmed-author:FiggWilliam DWD
,
pubmed-author:SausvilleEdward AEA
,
pubmed-author:SenderowiczAdrian MAM
,
pubmed-author:ZhaiSuopingS
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
905-11
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11978170-Antineoplastic Agents
,
pubmed-meshheading:11978170-Clinical Trials, Phase I as Topic
,
pubmed-meshheading:11978170-Clinical Trials, Phase II as Topic
,
pubmed-meshheading:11978170-Colonic Neoplasms
,
pubmed-meshheading:11978170-Cyclin-Dependent Kinases
,
pubmed-meshheading:11978170-Diarrhea
,
pubmed-meshheading:11978170-Drug Evaluation, Preclinical
,
pubmed-meshheading:11978170-Drug Therapy, Combination
,
pubmed-meshheading:11978170-Fatigue
,
pubmed-meshheading:11978170-Flavonoids
,
pubmed-meshheading:11978170-Humans
,
pubmed-meshheading:11978170-Infusion Pumps
,
pubmed-meshheading:11978170-Kidney Neoplasms
,
pubmed-meshheading:11978170-Lymphoma, Non-Hodgkin
,
pubmed-meshheading:11978170-Neoplasms
,
pubmed-meshheading:11978170-Neutropenia
,
pubmed-meshheading:11978170-Piperidines
pubmed:year
2002
pubmed:articleTitle
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development.
pubmed:affiliation
Center for Cancer Research, National Cancer Institute, Building 10 Room 5A01, 9000 Rockville Pike, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article
,
Review